Pathways Knowlegdes

Necessitatibus eius consequatur ex aliquid fuga eum quidem sint consectetur velit

Pathway DOIs Note
tetrapyrrole biosynthesis II

Accession ID: BioCyc:CAULONA1000_PWY-5189		 -
tetrapyrrole biosynthesis I

Accession ID: BioCyc:CAULONA1000_PWY-5188		 -
tetrapyrrole biosynthesis

Accession ID: BioCyc:CALBI_PWY3B3-2
  • 10.1007/bf00270144
  • 10.1016/s0021-9258(17)40440-6
  • 10.1016/s0162-0134(98)00005-1
 C. Hunter T, K. Mehra R. A role for HEM2 in cadmium tolerance1DNA sequence reported here has been submitted to GenBank (Accession number BankIt160246 AF038566).1. Journal of Inorganic Biochemistry. 1998 Mar;69(4):293–303. doi: 10.1016/s0162-0134(98)00005-1.; Urban-Grimal D, Labbe-Bois R. Genetic and biochemical characterization of mutants of Saccharomyces cerevisiae blocked in six different steps of heme biosynthesis. Molecular Genetics and Genomics. 1981 Sep;183(1):85–92. doi: 10.1007/bf00270144.; Gollub EG, Liu KP, Dayan J, Adlersberg M, Sprinson DB. Yeast mutants deficient in heme biosynthesis and a heme mutant additionally blocked in cyclization of 2,3-oxidosqualene. Journal of Biological Chemistry. 1977 May;252(9):2846–54. doi: 10.1016/s0021-9258(17)40440-6.
Porphyrin Metabolism

Accession ID: PathBank:SMP0000953		 -
Biochemical pathways: part I

Accession ID: WikiPathways:WP3604
  • 10.1016/s0303-2647(98)00019-7
 Michal G. On representation of metabolic pathways. Biosystems. 1998 Jun;47(1-2):1–7. doi: 10.1016/s0303-2647(98)00019-7. PMID: 9715748.
Hemesynthesis defects and porphyrias

Accession ID: WikiPathways:WP5169
  • 10.1111/bjh.14459
 Stein PE, Badminton MN, Rees DC. Update review of the acute porphyrias. Br J Haematol. 2017 Feb;176(4):527–38. doi: 10.1111/bjh.14459. PMID: 27982422.
Heme biosynthesis

Accession ID: WikiPathways:WP269		 -
Tyrosine metabolism and related disorders

Accession ID: WikiPathways:WP4506
  • 10.1038/s41598-020-57913-y
 Hendrikse NM, Holmberg Larsson A, Svensson Gelius S, Kuprin S, Nordling E, Syrén P. Exploring the therapeutic potential of modern and ancestral phenylalanine/tyrosine ammonia-lyases as supplementary treatment of hereditary tyrosinemia. Scientific Reports. 2020 Jan 28;10(1):1315. doi: 10.1038/s41598-020-57913-y.
Dihydropyrimidine Dehydrogenase Deficiency (DHPD)

Accession ID: PathBank:SMP0120694		 -
Non-Ketotic Hyperglycinemia

Accession ID: PathBank:SMP0120754		 -
Hyperglycinemia, Non-Ketotic

Accession ID: PathBank:SMP0120770		 -
Hereditary Coproporphyria (HCP)

Accession ID: PathBank:SMP0120492		 -
Porphyria Variegata (PV)

Accession ID: PathBank:SMP0120544		 -
Porphyrin Metabolism

Accession ID: PathBank:SMP0000024		 -
Dimethylglycine Dehydrogenase Deficiency

Accession ID: PathBank:SMP0000242		 -
Non-Ketotic Hyperglycinemia

Accession ID: PathBank:SMP0000223		 -
Dimethylglycine Dehydrogenase Deficiency

Accession ID: PathBank:SMP0000484		 -
Glycine and Serine Metabolism

Accession ID: PathBank:SMP0087338		 -
Glycine and Serine Metabolism

Accession ID: PathBank:SMP0087466		 -
3-Phosphoglycerate Dehydrogenase Deficiency

Accession ID: PathBank:SMP0120653		 -